Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-18

Clinical Trial Update: Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating symptom control and adherence in asthma patients treated with mepolizumab, using new prefilled d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nucala (mepolizumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING